GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Receivables Turnover

U-Neuron Biomedical (ROCO:6973) Receivables Turnover : 6.63 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. U-Neuron Biomedical's Revenue for the six months ended in Dec. 2023 was NT$15.02 Mil. U-Neuron Biomedical's average Accounts Receivable for the six months ended in Dec. 2023 was NT$2.27 Mil. Hence, U-Neuron Biomedical's Receivables Turnover for the six months ended in Dec. 2023 was 6.63.


U-Neuron Biomedical Receivables Turnover Historical Data

The historical data trend for U-Neuron Biomedical's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Receivables Turnover Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Receivables Turnover
- 18.12 16.69 12.99

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Receivables Turnover - 13.14 5.63 5.37 6.63

Competitive Comparison of U-Neuron Biomedical's Receivables Turnover

For the Biotechnology subindustry, U-Neuron Biomedical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U-Neuron Biomedical's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's Receivables Turnover falls into.



U-Neuron Biomedical Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

U-Neuron Biomedical's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=27.023 / ((2.051 + 2.109) / 2 )
=27.023 / 2.08
=12.99

U-Neuron Biomedical's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

Receivables Turnover (Q: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Dec. 2023 ) / ((Accounts Receivable (Q: Jun. 2023 ) + Accounts Receivable (Q: Dec. 2023 )) / count )
=15.023 / ((2.421 + 2.109) / 2 )
=15.023 / 2.265
=6.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U-Neuron Biomedical  (ROCO:6973) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


U-Neuron Biomedical Receivables Turnover Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical (ROCO:6973) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines